Tag: IPO
-
GigaDevice Opens Hong Kong Debut After $600 Million Offering
GigaDevice Sets the Stage for a Hong Kong Debut In a bold step that highlights the growing importance of Asia’s semiconductor memory sector, GigaDevice is preparing for its long-anticipated Hong Kong listing following a recent $600 million offering. The move positions the Shenzhen-based flash memory and solid-state drive (SSD) maker as a rising force in…
-
GigaDevice Set for Hong Kong Debut After $600 Million Offering
GigaDevice Eyes a Hong Kong Debut After a Major Financing Round GigaDevice, a rising star in the semiconductor memory space, is preparing for a Hong Kong debut following a monumental $600 million offering. The move underscores investor confidence in the company’s growth trajectory and the broader demand for advanced memory solutions amid a global chip…
-
Biren IC Enables Major Leap: Chinese Graphics Card Maker Raises $717M in Hong Kong IPO
Overview: Biren’s Hong Kong IPO Milestone Shanghai Biren Intelligent Technology Co. Ltd., a rising Chinese graphics card supplier better known as Biren, has successfully completed its initial public offering in Hong Kong, raising approximately $717 million. The issue priced at multiple shares and attracted strong demand from investors, underscoring confidence in China’s evolving GPU and…
-
Biren IPO: Shanghai Biren Intelligent Technology Raises $717 Million in Hong Kong Listing
Biren IPO Signals a Growing Push in China’s AI Hardware Market Shanghai Biren Intelligent Technology Co., a homegrown graphics card maker, has made a bold entry into the public markets, raising about $717 million in its initial public offering in Hong Kong. The company sold 284.8 million shares, marking a notable milestone for a Chinese…
-
Biren’s HK IPO Sets Stage for Chinese Graphics Card Growth
Overview of Biren’s IPO Milestone Shanghai Biren Intelligent Technology Co., a notable Chinese graphics card maker, has completed a landmark initial public offering in Hong Kong, raising approximately $717 million. The public listing involved the sale of 284.8 million shares, with strong demand from investors that reflected confidence in China’s burgeoning AI and high-performance computing…
-
Rs 4,100 crore windfall: IPO boom boosts India’s investment bankers in 2025
Overview: A record year for Indian investment bankers Investment bankers in India posted a historic haul in 2025, earning a combined roughly Rs 4,100 crore. The windfall is a direct consequence of a vibrant primary market, a surge in IPO listings, and robust deal pipelines that kept underwriters and advisory firms busy from January through…
-
IPO Boom 2025: Rs 4100 Cr Windfall for Indian Banks
Record Windfall for Investment Bankers in 2025 Indian investment bankers have posted a historic year, pocketing a combined 4100 crore rupees in 2025. The surge is primarily driven by a roaring primary market and a wave of initial public offerings (IPOs) that kept deal pipelines full from January through December. With several high-ticket listings dominating…
-
ICICI Prudential AMC IPO: Shares Jump 20% on Debut
ICICI Prudential AMC Makes a Striking Market Debut India’s asset management landscape got a bullish nudge as ICICI Prudential Asset Management Company (AMC) opened for trading with a 20% gain following its blockbuster initial public offering. The IPO, valued at 106 billion rupees ($1.17 billion), positioned ICICI Prudential AMC as a heavyweight in the country’s…
-
ICICI Prudential AMC’s Shares Jump 20% on Market Debut After Stellar IPO
Stellar IPO fuels a strong market debut for ICICI Prudential AMC Shares of ICICI Prudential Asset Management Company (AMC) surged about 20% in their trading debut, marking a confident start for one of India’s largest asset managers. The rally comes on the back of a blockbuster initial public offering (IPO) that raised 106 billion rupees…
-
Medline Survives Delays on Road to Biggest US 2025 IPO
Medline Bets Big on a Delayed IPO Medline Inc., a leading medical supplies company, is moving closer to a landmark initial public offering despite a history of delays that kept the market guessing. With investors showing renewed appetite for healthcare-focused listings, Medline’s path to the public markets is increasingly viewed as worthwhile, enough to potentially…